HFA 2018: GENETIC-AF -Pharmacogenetic Guided Beta-blocker Therapy

Published: 05 Jun 2018

  • Views:

    Views Icon 199
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Prof William Abraham (Columbus, US) discusses GENETIC-AF - Phase ii trial of pharmacogenetic guided beta-blocker therapy with bucindolol vs. metoprolol for the prevention of atrial fibrillation/flutter in heart failure.

Filmed by Radcliffe Cardiology on site at HFA 2018 in Vienna, AT.